From Wikipedia, the free encyclopedia
Glycemic efficacy refers to the capacity of regulated glycemic levels to produce an effect in people with
diabetes and
heart disease .
[1] According to
Zeev Vlodaver ,
Robert F. Wilson and
Daniel J. Garry , "
exenatide and
liraglutide are synthetic GLP-1 agonists and have demonstrated glycemic efficacy (HbA1c reductions of between 0.7 and 2%) associated with mild weight loss."
[2]
Glyburide ,
metformin and
rosiglitazone have been assessed as a monotherapy in the durability of glycemic efficacy.
[3]
References
^ Marso, Steven P.; Stern, David M. (2004).
Diabetes and Cardiovascular Disease: Integrating Science and Clinical Medicine . Lippincott Williams & Wilkins. p. 229.
ISBN
978-0-7817-4053-1 . Retrieved 29 April 2012 .
^ Vlodaver, Zeev; Wilson, Robert F.; Garry, Daniel J. (31 January 2012).
Coronary Heart Disease: Clinical, Pathological, Imaging, and Molecular Profiles . Springer. p. 475.
ISBN
978-1-4614-1474-2 . Retrieved 29 April 2012 .
^ Holt, Richard I. G.; Cockram, Clive; Flyvbjerg, Allan; Goldstein, Barry J. (26 July 2011).
Textbook of Diabetes . John Wiley & Sons. p. 861.
ISBN
978-1-4443-4806-4 . Retrieved 29 April 2012 .